Sato H - Search Results

1

Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors.

Miyazaki Y, Matsunaga S, Tang J, Maeda Y, Nakano M, Philippe RJ, Shibahara M, Liu W, Sato H, Wang L, Nolte RT. Miyazaki Y, et al. Among authors: sato h. Bioorg Med Chem Lett. 2005 May 2;15(9):2203-7. doi: 10.1016/j.bmcl.2005.03.034. Bioorg Med Chem Lett. 2005. PMID: 15837294

2

Anilinopyrazole as selective CDK2 inhibitors: design, synthesis, biological evaluation, and X-ray crystallographic analysis.

Tang J, Shewchuk LM, Sato H, Hasegawa M, Washio Y, Nishigaki N. Tang J, et al. Among authors: sato h. Bioorg Med Chem Lett. 2003 Sep 15;13(18):2985-8. doi: 10.1016/s0960-894x(03)00630-9. Bioorg Med Chem Lett. 2003. PMID: 12941317

3

4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors.

Maeda Y, Nakano M, Sato H, Miyazaki Y, Schweiker SL, Smith JL, Truesdale AT. Maeda Y, et al. Among authors: sato h. Bioorg Med Chem Lett. 2004 Aug 2;14(15):3907-11. doi: 10.1016/j.bmcl.2004.05.064. Bioorg Med Chem Lett. 2004. PMID: 15225695

4

Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases.

Miyazaki Y, Nakano M, Sato H, Truesdale AT, Stuart JD, Nartey EN, Hightower KE, Kane-Carson L. Miyazaki Y, et al. Among authors: sato h. Bioorg Med Chem Lett. 2007 Jan 1;17(1):250-4. doi: 10.1016/j.bmcl.2006.09.050. Epub 2006 Oct 5. Bioorg Med Chem Lett. 2007. PMID: 17027260

5

Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2.

Miyazaki Y, Tang J, Maeda Y, Nakano M, Wang L, Nolte RT, Sato H, Sugai M, Okamoto Y, Truesdale AT, Hassler DF, Nartey EN, Patrick DR, Ho ML, Ozawa K. Miyazaki Y, et al. Among authors: sato h. Bioorg Med Chem Lett. 2007 Mar 15;17(6):1773-8. doi: 10.1016/j.bmcl.2006.12.077. Epub 2006 Dec 24. Bioorg Med Chem Lett. 2007. PMID: 17276055

6

Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors.

Hasegawa M, Nishigaki N, Washio Y, Kano K, Harris PA, Sato H, Mori I, West RI, Shibahara M, Toyoda H, Wang L, Nolte RT, Veal JM, Cheung M. Hasegawa M, et al. Among authors: sato h. J Med Chem. 2007 Sep 6;50(18):4453-70. doi: 10.1021/jm0611051. Epub 2007 Aug 4. J Med Chem. 2007. PMID: 17676829

7

Rational design of 4-amino-5,6-diaryl-furo[2,3-d]pyrimidines as potent glycogen synthase kinase-3 inhibitors.

Miyazaki Y, Maeda Y, Sato H, Nakano M, Mellor GW. Miyazaki Y, et al. Among authors: sato h. Bioorg Med Chem Lett. 2008 Mar 15;18(6):1967-71. doi: 10.1016/j.bmcl.2008.01.113. Epub 2008 Feb 2. Bioorg Med Chem Lett. 2008. PMID: 18280153

8

Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.

Tang J, Hamajima T, Nakano M, Sato H, Dickerson SH, Lackey KE. Tang J, et al. Among authors: sato h. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4610-4. doi: 10.1016/j.bmcl.2008.07.019. Epub 2008 Jul 10. Bioorg Med Chem Lett. 2008. PMID: 18662874

9

Prediction of multiple binding modes of the CDK2 inhibitors, anilinopyrazoles, using the automated docking programs GOLD, FlexX, and LigandFit: an evaluation of performance.

Sato H, Shewchuk LM, Tang J. Sato H, et al. J Chem Inf Model. 2006 Nov-Dec;46(6):2552-62. doi: 10.1021/ci600186b. J Chem Inf Model. 2006. PMID: 17125195

10

Arachidonic acid amide inhibitors of gap junction cell-cell communication.

Boger DL, Sato H, Lerner AE, Guan X, Gilula NB. Boger DL, et al. Among authors: sato h. Bioorg Med Chem Lett. 1999 Apr 19;9(8):1151-4. doi: 10.1016/s0960-894x(99)00148-1. Bioorg Med Chem Lett. 1999. PMID: 10328303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,892 results

Search Page